Aberrant methylation of tissue factor pathway inhibitor-2 is a biomarker for HSIL and squamous cell carcinoma of the cervix

被引：0
|
作者：
Bin Yang [1 ]
Ji, Xin [1 ]
Scheidemantel, Thomas [1 ]
Abu Shahin, Fadi [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
CANCER CYTOPATHOLOGY | 2007年 / 111卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PF7
引用
收藏
页码：349 / 350
页数：2
相关论文
共 50 条
  • [31] Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue.
    Sierko, E
    Wojtukiewicz, MZ
    Zimnoch, L
    Kozlowski, L
    Sulkowski, S
    Kisiel, W
    BLOOD, 2002, 100 (11) : 486A - 486A
  • [32] Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
    Etsuko Miyagi
    Noriaki Arakawa
    Kentaro Sakamaki
    Naho Ruiz Yokota
    Takeharu Yamanaka
    Yuki Yamada
    Satoshi Yamaguchi
    Shoji Nagao
    Yasuyuki Hirashima
    Yuka Kasamatsu
    Hisamori Kato
    Tae Mogami
    Yohei Miyagi
    Hiroshi Kobayashi
    International Journal of Clinical Oncology, 2021, 26 : 1336 - 1344
  • [33] Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
    Arakawa, Noriaki
    Kobayashi, Hiroshi
    Yonemoto, Naohiro
    Masuishi, Yusuke
    Ino, Yoko
    Shigetomi, Hiroshi
    Furukawa, Naoto
    Ohtake, Norihisa
    Miyagi, Yohei
    Hirahara, Fumiki
    Hirano, Hisashi
    Miyagi, Etsuko
    PLOS ONE, 2016, 11 (10):
  • [34] Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
    Miyagi, Etsuko
    Arakawa, Noriaki
    Sakamaki, Kentaro
    Yokota, Naho Ruiz
    Yamanaka, Takeharu
    Yamada, Yuki
    Yamaguchi, Satoshi
    Nagao, Shoji
    Hirashima, Yasuyuki
    Kasamatsu, Yuka
    Kato, Hisamori
    Mogami, Tae
    Miyagi, Yohei
    Kobayashi, Hiroshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (07) : 1336 - 1344
  • [35] Tissue factor pathway inhibitor 2 (TFPI2) is a potential serum biomarker for clear cell renal carcinoma
    Ito, Hiroki
    Jikuya, Ryosuke
    Myoba, Shohei
    Tatenuma, Tomoyuki
    Noguchi, Go
    Ueno, Daiki
    Ito, Yusuke
    Komeya, Mitsuru
    Muraoka, Kentaro
    Yao, Masahiro
    Hasumi, Hisashi
    Nakaigawa, Noboru
    Makiyama, Kazuhide
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas
    Konduri, SD
    Osman, FA
    Rao, CN
    Srinivas, H
    Yanamandra, N
    Tasiou, A
    Dinh, DH
    Olivero, WC
    Gujrati, M
    Foster, DC
    Kisiel, W
    Kouraklis, G
    Rao, JS
    ONCOGENE, 2002, 21 (06) : 921 - 928
  • [37] Nucleotide sequence of the gene encoding murine tissue factor pathway inhibitor-2
    Kazama, Y
    Kamei, S
    Kuijper, JL
    Foster, DC
    Kisiel, W
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (01) : 141 - 147
  • [38] Molecular cloning, expression, and characterization of bovine tissue factor pathway inhibitor-2
    Du, X
    Deng, FM
    Chand, HS
    Kisiel, W
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 417 (01) : 96 - 104
  • [39] Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
    Iochmann, Sophie
    Blechet, Claire
    Chabot, Valerie
    Saulnier, Annabelle
    Amini, Anica
    Gaud, Guillaume
    Gruel, Yves
    Reverdiau, Pascale
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (05) : 457 - 467
  • [40] Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
    Sophie Iochmann
    Claire Bléchet
    Valérie Chabot
    Annabelle Saulnier
    Aniça Amini
    Guillaume Gaud
    Yves Gruel
    Pascale Reverdiau
    Clinical & Experimental Metastasis, 2009, 26 : 457 - 467
12345